However, although patients exposed to IM (thiopurines) showed higher rates of new/recurrent cancer when compared to patients without IM, the difference did not reach statistical significance, leading to the conclusion that IM treatment was not associated with an increased risk of incident cancer [ 52 ].
← all excerpts
Inflammatory Bowel Disease Treatment in Cancer Patients-A Comprehensive Review.
1
—
—